Biotech China 2014

View Profile


Pre/Non Reviewed Papers, Proceedings

Year Title Authors
1. 2009 A long-term open-label extension study examining the steroid-sparing effects of corticorelin acetate in patients with cerebral tumors.
2. 2008 Vogelbaum M. Brain Tumor Webcast Course (CME). Primary Malignant Gliomas
3. 2008 The Significance of Granular Cells in Gliomas
4. 2008 1H MRSI Detection of Elevated Total Creatine in Brain Cancer: A Cautionary Tale.
5. 2008 The Pregnant Neurosurgeon: Not an Oxymoron
6. 2007 Women in Neurosurgery Newsletter
7. 2007 Automated Analysis of 1H Magnetic Resonance Metabolic Imaging Data as an Aid to Clinical Decision-Making in the Evaluation of Intracranial Lesions
8. 2007 Training the Trainer, Physician Education Video
9. 2007 Multidisciplinary Perspectives on Management of Glioblastoma Multiforme
10. 2006 Therapeutic Strategies for Newly Diagnosed High Grade Gliomas
11. 2006 Brain Tumor Stories” patient education video, The Wellness Community/ Schering-Plough Pharmaceuticals
12. 2006 Phase I/II Trial of Twice-Daily Temozolomide and Celecoxib for Treatment of Relapsed Malignant Glioma: Final Data
13. 2006 Treatment with Temozolomide for Malignant Gliomas: Is Rechallenge with Alternative Dosing Regimens Successful?
14. 2006 Brain Tumor Imaging Initiatives at the Citicorp Biomedical Imaging Center.
15. 2006 Case Studies in Newly Diagnosed GBM – New York Presbyterian Hospital/ Weill Cornell Medical Center
16. 2005 Case Studies in Newly Diagnosed GBM – Weill Cornell Medical Center
17. 2005 Interdisciplinary Collaboration Spurs Neuro-oncology Initiatives.
18. 2005 Brain Tumor Facts and Information Sheet
19. 2005 Carmustine implant: Future Directions.
20. 2005 Phase I/II Trial of a Twice-Daily Regimen of Temozolomide and Celecoxib for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma
21. 2005 Preliminary Assessment of the Therapeutic Efficacy of BCNU Chemotherapy Wafers (Gliadel) Using MR Spectroscopic Imaging at 3.0 Tesla
22. 2004 Phase I/II Trial of a Twice-Daily Regimen of Temozolomide and Celecoxib for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma
23. 2004 New York Presbyterian Neuroscience Newsletter
24. 2004 Pannullo S and Serventi J
25. 2004 Stereotactic Radiosurgery and Brachytherapy for Brain Tumors
26. 2004 Immunotherapy Approaches to High-Grade Gliomas: Differential Responsiveness or Synergy? A Case Report. The Cleveland Clinic Brain Tumor Institute presents “Neuro-Oncology 2004: Current Concepts
27. 2003 Neuro-Oncology Web Content
28. 2003 Synergistic efficacy of sequential fractionated Stereotactic Radiosurgery plus paclitaxel and adoptive cellular immune therapy using Interleukin-2 and activated killer cells.
29. 2003 Temozolomide plus Celecoxib for Treatment of Malignant Gliomas. Proceedings of the American Society of Clinical Oncology
30. 2002 Magnetic Resonance Spectroscopy Assessment of Oligodendroglioma Response to Chemotherapy. Society for Neuro-Oncology
31. 2002 Temozolomide Plus Celecoxib for Treatment of Malignant Gliomas, Proceedings of the Society for Neuro-Oncology
32. 2001 Fractionated Stereotactic Radiosurgery for Acoustic Neuroma. Proceedings of the American Association of Physicists in Medicine Annual Meeting
33. 2001 Fractionated Stereotactic Radiosurgery and Taxol for Recurrent Glioblastoma Multiforme. Poster Presentation. ASTRO Annual Meeting
34. 2001 Fractionated Stereotactic Radiosurgery for Acoustic Neuroma. Proceedings of the American Society of Clinical Oncology
35. 1993 Radiofrequency rhizotomy for trigeminal neuralgia in multiple sclerosis: an underutilized tool. Congress of Neurological Surgeons, 43rd Meeting
36. 1992 MRI Changes in Intracranial Hypotension
37. 1991 Seizures after Bone Marrow Transplant.
38. 1986 Neuropsychiatric Complications of Steroids.


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.